Jun He Law Offices P.C.
ErbB/BTK inhibitors
Disclosed are compounds inhibiting ErbBs (e.g., EGFR or Her 2), especially mutant forms of ErbBs, and BTK, pharmaceutically acceptable salts, hydrates, solvates or stereoisomers thereof and pharmaceutical compositions comprising the compounds. The compound and the pharmaceutical composition can effectively treat ErbBs (especially mutant forms of ErbBs) or BTK associated diseases, including cancer.
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
C C A C C A C C A C C A A A C A A A C
C07D C07D A61P C07D C07D A61K C07D C07D A61P C07D C07D A61P A61K A61K C07D A61P A61P A61K C07C
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Changmao Xiang Rumin Xiaolin Honchung Wei Zhenfan Wengeng Hao Zhengtao
Shen Chen Wang Zhang Tsui Zhu Yang Liu Zou Li